Avon Dental Group Receives Exclusive ACE™ Certification in the Diagnosis and Treatment of Periodontal Disease

The doctors and staff of Avon Dental Group recently received ARESTIN^® Certified Expert (ACE^™) certification after completing comprehensive training on the diagnosis and treatment of periodontal disease. The exclusive ACE^™ certification is important because periodontal disease is the most common chronic bacterial infection in adults, affecting 35.7 million Americans, and is the leading cause of adult tooth loss.  In addition, the Surgeon General has issued a warning regarding the possible relationship between periodontal disease and a variety of medical conditions, including cardiovascular disease, diabetes, and osteoporosis. ARESTIN^® (minocycline hydrochloride) Microspheres, 1 mg is a locally administered antibiotic (LAA) manufactured by OraPharma, Inc. Clinical studies have proven that ARESTIN^® used as an adjunct to scaling and root planing (SRP) is more effective than SRP alone in eliminating periodontal pathogens. SRP is a manual procedure that is performed by a dentist or registered dental hygienist, whereby bacterial pathogens residing in the plaque and tartar are removed from below the gum line while smoothing the tooth’s root surfaces to promote healing and prevent plaque from again taking hold.  During SRP, many dentists prescribe or administer an LAA to treat the periodontal infection and promote healing. One such LAA is OraPharma’s ARESTIN^®.  ARESTIN^® is an effective antibiotic that kills the bacteria that cause periodontal disease. In order to earn ACE^™ certification, the doctors and hygienists of ADG were trained and tested in the following areas: accurate diagnosis of periodontal disease, effective treatment protocol, accurate insurance coding, the benefits of using LAAs, staff and patient education, encouraging patient compliance, patient monitoring, and the possible systemic health risks of untreated periodontal disease.

Advertisement